OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Ocugen, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.79+0.01 (+0.90%)
Close on Oct 19, 2026
- Market cap
- $266.64M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Ocugen from other investors
No posts about OCGN yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.